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The emergence of resistance to antimicrobial agents in bacterial pathogens is a worldwide problem that has been 
associated with inappropriate use in human and veterinary medicine. Between August 2004 and July 2005 stool 
samples from 380 patients were cultured for enteric pathogens and characterized by Polymerase Chain Reaction 
for the presence of virulence properties. Patients were from Narok and Kajiado Districts of Kenya, mainly 
populated by the Maasai community majority of who practice traditional medicine. 218 patients were from 
Narok District Hospital and 62 from Entosopia Clinic in Kajiado. A total of 107 E. coli and 35 Shigella isolates 
were tested.  
Antibiotic susceptibility testing was done using the E-test strips containing Tetracycline, Gentamicin, 
Chloramphenicol, Fosfomycin, Amoxicillin/Clavulanic acid, Trimethoprim/Sulphamethoxazole, Ticarcillin/ 
Clavulanic acid and Ciprofloxacin. The resistance frequencies did not differ significantly between other E. coli 
and Shiga toxigenic E. coli, respectively; Gentamicin (3% vs. 3%), Chloramphenicol, (24% vs. 23%) and 
ampicillin (25% vs. 23%), Tetracycline (63% vs. 68%), Fosfomycin (44% vs. 54%) and 
Trimethoprim/Sulphamethoxazole (84% vs. 84%). Overall antibiotic resistance levels were at much lower levels 
than those reported from the rest of Kenya, possibly due to the lower levels of exposure and usage of 
antimicrobials among the Maasai community. 
 
 
[Afr J Health Sci. 2011; 19:70-75] 
 
Introduction 
Diarrhoea is a significant health problem worldwide, 
especially in the developing world where adequate 
health facilities and proper sanitation are lacking [1]. 
Globally diarrheal diseases account for an estimated 
2.2 million deaths of children below 5 years annually, 
[2,3]. The progressive increase in antimicrobial 
resistance among enteric pathogens particularly 
Shigella, Vibrio cholerae, Enteropathogenic E. coli, 
Salmonella Typhi and S. Enteriditis species is 
becoming a critical concern worldwide, particularly in 
the developing world where there are high rates of 
diarrheal diseases which are associated with mortality. 
This also affects travelers to these regions. 
Antimicrobial resistance in developing world is most 
likely related to the frequent unrestricted use of over-
the-counter drugs without medical supervision [4].  
The emergence and spread of antibiotic resistance in 
bacteria is of medical importance and poses serious 
constraints on the options available for the treatment of 
many infections. This problem has been brought into 
prominence by the recent widespread outbreaks of 
enteric diseases caused by drug resistant organisms [5, 
6]. Among enteric pathogens, major epidemics of 
infection with antibiotic resistant Shigella have 
occurred in Latin America, Asia and Africa [7, 8, 9]. In 
Kenya, diarrheal illnesses ranked 4th after Malaria, 
upper respiratory tract infections and skin infection 
[10]. A major outbreak of multi-drug resistant Shigella 
dysenteriae I, occurring concurrently with Vibrio 
cholerae serovar O1 Ogawa was reported along the 
coastline of Kenya [11]. This strain of S. dysenteriae 
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was found to be resistant to ampicillin, Tetracycline, 
Chloramphenicol, and cotrimaxazole but sensitive to 
gentamycin, nalidixic acid and kanamycin, apart from 
one strain that was resistant to kanamycin. However 
most V. cholerae strains were sensitive to Gentamicin, 
nalidixic acid, kanamycin, Tetracycline, 
Chloramphenicol and a few were resistant to 
ampicillin. Also multi-drug resistant enteroaggregative 
E .coli serotype O44 associated with acute and 
persistent diarrhea was reported in Kenyan children 
[12]. A number of studies done at a public teaching 
hospital in Kenya in 1991 and 1992 [13, 14] recorded a 
prevalence of over 50% to ampicillin and 80% to 100% 
resistance to Tetracycline among Salmonella and 
Shigella isolates causing nosocomial infections during 
the period 1986-1990. A more recent study in Kenya 
further attests to this trend in which about 70% of the 
E. coli isolated was resistant to Tetracycline, ampicillin 
and sulphamethoxazole-trimethoprim [15]. 
 
Materials and Methods 
After obtaining informed consent, stool samples from 
380 outpatients with diarrhea (318 from Narok District 
Hospital and 62 from Entosopia Clinic) were collected 
in sterile plastic containers. The specimens were 
transferred into Cary-Blair transport media (MML 
Diagnostics Inc, Troutdale, Oregon, USA), labeled 
only with a unique study number and then placed in an 
insulated box with ice packs and transported to the 
Kenya Medical Research Institute Centre for 
Microbiology laboratory where they were processed 
within 6 hours of collection.  
All stool samples were plated onto MacConkey agar, 
Xylose-Lysine-deoxycholate agar XLD), Sorbital-
MacConkey agar (for detection of O157 STEC) and 
Campylobacter blood-free agar. Initially selenite broth 
was used for enrichment purposes. The plates were 
incubated aerobically at 37
o
C for 18 – 24 hrs, with the 
exception of Campylobacter plates, which were 
incubated at 42
o
C in microaerophilic conditions for 48 
hrs [16]. 
After overnight growth at 37
o
C one to two suspect 
colonies each of Shigella and Salmonella and five to 
ten single colonies with typical E. coli morphology 
were selected and characterized on the basis of their 
biochemical reactions using BBL Enterotubes™ II. 
(Becton Dickson Microbiology Systems Sparks, 
Maryland USA) 
The strains identified as Salmonella, Shigella or E. coli 
by their colonial morphology and biochemical 
properties were further serotyped using O-antigen and 
H-antigen antisera (Denka Seiken Co LTD, Tokyo- 
Japan) by slide agglutination assays as previously 
described [17]. 
Antibiotic Susceptibility Testing by MIC method 
A total of 107 E. coli isolates of which 31 were STEC 
and 76 isolates from other pathogenic E. coli ( ETECs, 
Eagg, Einv and EPEC, including 35 isolates of Shigella 
spp). were tested for susceptibility. 
The E-test method (AB Biodisk) was used to screen for 
the antibiotic susceptibility patterns. The minimum 
inhibitory concentration (MIC) susceptibility test was 
determined in accordance with the manufacturer's 
guidelines (AB Biodisk, Sweden). The 0.5 McFarland 
standards isolates were inoculated onto Mueller Hinton 
agar plates by swabbing evenly in three directions. The 
E-test strip (obtained from the refrigerator at 4
o
C) was 
applied to each plate with sterile forceps with lowest 
concentration toward the center of the agar plate. The 
plates were then incubated at 30 to 35 °C for 24 hours. 
The E-test MIC values were read directly from the E-
test strip MIC scale. The following antibacterial agents: 
Fosfomycin (Fm), Ciprofloxacin (Cip), Cefotaxime 
(Ctx), Ticarcillin/Clavulanic acid (Ctl), Gentamicin 
(Gn), trimethoprim-sulfamethoxazole (Sxt), ampicillin 
(Am), Chloramphenicol (Chl) and Tetracycline (Te) 
were used as guided by CLS (2005) criteria. The 
concentration gradient of each antimicrobial agent on 
the E-test strips was 0.016 to 256µg/ml with the 
exception of Ciprofloxacin and co-trimoxazole for 




The antibiotic susceptibility testing data are shown in 
Table 1. Of the 76 diarrheagenic E.coli isolates (31 
ETEC, 20 EPEC,  14 Eagg and  11 Einv), 84% were 
resistant to SXT, 63% were resistant to TC,  44% were 
resistant to FM and  24% were resistant to CHL. Lower 
levels of resistance were observed for gentamycin and 
ampicilin  3% and  5% respectively. All these isolates 
were fully sensitive to CIP, CTX and CTL. The 
traditional antibiotics, including CHL, TC and STX 
showed low activity against these E.coli strains (MIC 
at which 90% of these isolates tested are inhibited 
[MIC90] of 64 mg/liter for CHL and MIC90 of 1024 
mg/liter.  
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   Table 1: Antibiotic susceptibilities of diarrheagenic E.coli and Shigella strains.                                                                                                                                         
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Out of 35 STEC strains, 31 were tested for all the 
antibiotics. The resistance frequencies did not differ 
significantly between other E. coli pathotypes and 
STEC respectively (p>0.05), that is gentamycin (3% 
vs. 3%), and Chloramphenicol, (24% vs. 23%) with the 
exception of ampicillin (5% vs. 23%). The frequencies 
were slightly higher for Tetracycline (63% vs. 68%), 
Fosfomycin (44% vs. 54%) and 
Trimethoprim/Sulphamethoxazole (84% vs. 84%). 
Shigella 
Thirty five Shigella strains tested showed that high 
levels of resistance for TC and SXT 77% and 91% 
respectively. TC and SXT showed very low activity 
against Shigella strains with MIC90’s of 192 and 32 
mg/liter, respectively. All Shigella strains were 100% 
sensitive to CIP and Gen. All Shigella strains were not 
tested for two antibiotics CTX and CTL. 
 
Discussion 
There are several reports on the multiple antimicrobial 
resistance among strains of pathogenic E. coli in Kenya 
[12, 18, 15]. However, the resistance rates observed in 
this study are much lower than those that have been 
reported from the rest of Kenya. As compared to our 
study which showed lower prevalence of resistance to 
AM, CHL, TC for STEC and non STEC strains, a 
study by Kariuki et al  in 1997 recorded multiple 
resistance rates in E. coli as high as 86% to 
Tetracycline and 89% resistance to ampicillin [18].  
Study results showed moderate activity against E.coli 
strains for AM and CHL. The overall occurrence of 
STEC drug resistant isolates range from 3% resistance 
to Gentamycin to 84% for 
Trimethoprim/Sulphamethoxazole for both STEC and 
none STEC. The MIC of STEC isolates showed almost 
similar patterns as those of non STEC with an 
exception of Ampicilin drug where non-STEC showed 
lower levels of resistance at 3% as compared to 23% 
for STEC.  
Variation in resistance frequencies of STEC and non 
STEC strains agree with findings of a similar study on 
antibiotic resistance (8% vs. 26%), [19]. The 
observation that all STEC and non STEC strains were 
fully sensitive to Ciprofloxacin is important 
considering that fluoroquinolones are used to treat a 
range of E. coli infections in humans. Other researchers 
in the developed countries found low levels of 
resistance of E. coli isolates to Ciprofloxacin ranging 
from 1% to 5% [20, 21].  The use of antibiotics to treat 
patients with STEC infections has been quite 
controversial. Most clinicians experienced in the 
management of STEC infections in the United States 
and Canada have found that antimicrobial agents at 
best have little clinical effect and at worst causes harm, 
for example increase the chances of acquiring 
Hemolytic Uremic Syndrome (HUS) [22, 23]  
All Shigella isolates were fully sensitive to 
Ciprofloxacin and Gentamycin. Moreover, as 
compared to E.coli isolates the resistance of Shigella 
isolates was much higher to antimicrobials which 
ranged from 29% resistant to chloramphenical and to 
91% resistance to trimethoprim-sulphamethoxazole. 
The increase in resistance of Shigella species to 
trimethoprim- sulphamethoxazole and to ampicillin has 
been reported world wide [21, 24]. Also in Kenya, a 
study by Kariuki et al reported the resistance rate of 
Shigella spp. to trimethoprim/sulphamethoxazole and 
ampicillin to be as high as 100% for both drugs [25]. In 
this study, resistance rates of Shigella spp. to these 
antibiotics were not as high as those reported in 
Burundi [26], Zimbabwe [27] and in the coastal 
province of Kenya [11].  
The level of antimicrobial resistance were much lower 
compared with those reported elsewhere [28, 29, 30]. 
The results of STEC strains from our study could be 
different in that the Maasai people have not been 




We observed low levels of antibiotic resistance among 
the Maasai communities who may not have been 
grossly exposed to antibiotics and still practice the use 
of traditional medicine. The antibiotics that have 
developed resistance in the rest of Kenya can still be 
administered to the patients in the Maasai 
communities. 
The overall antibiotic resistance levels were at much 
lower levels than those reported from the rest of 
Kenya, possibly due to the lower levels of exposure 
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